Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

EnteroMedics Inc.

www.enteromedics.com

Latest From QuatRx Pharmaceuticals Co.

Keeping Track: FDA Approves First Rx DHEA, Receives Applications For Midostaurin, Gesulkumab, Biosimilar Avastin

The latest drug development news and highlights from our FDA Performance Tracker.

Approvals Regulation

Viking sets sail with 5 Ligand assets

Viking Therapeutics licensed five assets from Ligand Pharmaceuticals, including a clinical-stage type 2 diabetes program that the private San Diego-based company has been working on since it was founded in late 2012.

Metabolic Disorders Gastrointestinal

Deals Shaping The Medical Industry, September 2013

Derived from Strategic Transactions, Elsevier Business Intelligence’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing.

BioPharmaceutical Medical Device

Women’s Health: Moving Beyond Gynecology To Sexuality

Big Pharma’s exodus from women’s health has created opportunities for biotech start-ups, which hope to tap into potentially huge markets. Profiles of Evestra Pharmaceuticals, S1 Biopharma, and Sprout Pharmaceuticals.

BioPharmaceutical
See All

Company Information

  • Industry
  • Medical Devices
    • Implantable Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
  • Therapeutic Areas
  • Gastrointestinal
  • Metabolic Disorders
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • EnteroMedics Inc.
  • Senior Management
  • Dan Gladney, Pres. & CEO
    Scott Youngstrom, CFO & COO
    Scott A Shikora, MD, CMO
    Paul Hickey, SVP, Mktg. & Reimbursement
    Peter Delange, SVP, Ops. & Bus. Dev.
    Nick A Ansari, SVP, Sales
  • Contact Info
  • EnteroMedics Inc.
    Phone: (651) 634-3003
    2800 Patton Rd.
    St. Paul, MN 55113
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register